HBK INVESTMENTS L P
Q3 2025 13F-HR Holdings
Net value change ($000)
+6,168,034
(209.5%)
New positions
105
Sold out positions
10
Turnover %
118.5%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2025
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| CYBR | 1,135,403 | NEW |
| VRNA | 454,966 | NEW |
| GTLS | 425,894 | NEW |
| NSC | 381,521 | NEW |
| LBRDA | 360,590 | NEW |
| DAY | 296,227 | NEW |
| Merus N.V. | 268,328 | NEW |
| COOP | 202,521 | NEW |
| AL | 175,038 | NEW |
| Metsera, Inc. | 167,456 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| KEL | -526,678 | -76.3% |
| BPMC | -410,294 | -100.0% |
| AZEK | -382,546 | -100.0% |
| Enstar Group LTD | -250,095 | -100.0% |
| CHX | -211,113 | -100.0% |
| DNB | -195,400 | -100.0% |
| SKAA | -148,150 | -100.0% |
| SpringWorks Therapeutics, Inc. | -122,592 | -100.0% |
| RDFN | -63,637 | -100.0% |
| G | -60,327 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
2,329,873
(25.6% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|